← Back to Search

Other

Avocado for Prediabetes (AVOC4 Trial)

N/A
Waitlist Available
Led By Britt Burton-Freeman, ph.D
Research Sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up time 0-180 minutes
Awards & highlights

AVOC4 Trial Summary

This trial found that three different evening snacks had different effects on morning fasting glucose and insulin concentrations in individuals with prediabetes.

Who is the study for?
This trial is for men and women aged 25-70 with prediabetes, defined as fasting blood glucose between 100-125 mg/dL. Participants should be nonsmokers in good health without cardiovascular or metabolic diseases, not on interfering medications, and able to follow the study's diet and testing protocols.Check my eligibility
What is being tested?
The study compares three evening snacks: low-fat yogurt; avocado; and a combination of low-fat yogurt with added fiber and fat. It aims to observe their effects on morning fasting glucose levels as well as post-meal insulin concentrations in prediabetic individuals.See study design
What are the potential side effects?
Potential side effects are not explicitly listed but may include digestive discomfort due to dietary changes. As this is a nutritional intervention trial focusing on common foods, significant side effects are unlikely.

AVOC4 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time 0-180 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and time 0-180 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in plasma Interleukin (IL)-6 concentration
Changes in plasma glucose concentration
Changes in plasma insulin concentration
+2 more

AVOC4 Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: control snackExperimental Treatment1 Intervention
Low-fiber, low-fat
Group II: Avocado snackExperimental Treatment1 Intervention
1 avocado
Group III: control snack + fiber supplement + vegetable oilPlacebo Group1 Intervention
high fat, high fiber control

Find a Location

Who is running the clinical trial?

Hass Avocado BoardOTHER
12 Previous Clinical Trials
711 Total Patients Enrolled
Clinical Nutrition Research Center, Illinois Institute of TechnologyLead Sponsor
53 Previous Clinical Trials
2,870 Total Patients Enrolled
Britt Burton-Freeman, ph.DPrincipal InvestigatorIllinois Institute of Technology

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are senior citizens excluded from participating in this research endeavor?

"This research requires patients between the ages 25 and 70; there are 11 studies accessible to those below 18 and 160 for seniors."

Answered by AI

What type of individuals are best suited for inclusion in this research trial?

"This clinical trial seeks 40 individuals aged between 25 and 70 that demonstrate pre-diabetic symptoms. To be eligible, participants must also: abstain from any medications that would interfere with the desired outcomes; possess a fasting blood glucose concentration of 100 to 125 mg/dL at screening visit; have a systolic or diastolic pressure of 120 - 160 mmHg or 80 -100 mmHg respectively during screening; not partake in smoking for over 12 months (past smokers are accepted); judged to be in good health based on medical history; provide informed consent and comply with protocol requests such as dietary plans, scheduled visits, questionnaires"

Answered by AI

Is recruitment for this scientific experiment still ongoing?

"According to the information located on clinicaltrials.gov, recruitment for this specific medical trial has ceased as of July 19th 2022. However, there are presently 198 other studies actively enrolling patients."

Answered by AI
~18 spots leftby Apr 2025